Telomir Pharmaceuticals, Inc. (NASDAQ:TELO – Get Free Report)’s share price traded down 2.4% during trading on Thursday . The company traded as low as $6.51 and last traded at $6.80. 9,254 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 67,604 shares. The stock had previously closed at $6.97.
Telomir Pharmaceuticals Stock Down 2.4 %
The business’s 50 day moving average is $7.38.
Telomir Pharmaceuticals Company Profile
Telomir Pharmaceuticals, Inc, a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. The company develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy health problems.
See Also
- Five stocks we like better than Telomir Pharmaceuticals
- What is a Death Cross in Stocks?
- Hasbro’s Management Made All the Right Calls This Quarter
- What Makes a Stock a Good Dividend Stock?
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- The “How” and “Why” of Investing in 5G Stocks
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Telomir Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telomir Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
